Lyxumia As Fourth GLP-1 To Market? Not To Worry, Says Zealand CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
The Danish biotech has partnerships with major players in several therapeutic areas, including a successful tie-up with Sanofi, and is looking to partner some of its other pipeline programs as well.